New depression drug enters Mid-Stage testing
Disease control
Recruiting now
This study aims to find out if an experimental medication called DT-101 can help reduce symptoms of major depression. Researchers will compare DT-101 against a placebo (inactive treatment) in 300 adults with recurrent depression over about 6 weeks. Participants will visit the cli…
Phase: PHASE2 • Sponsor: Draig Therapeutics Ltd • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC